StockTipsArenaBeta

Alkem Laboratories Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹5,015+11.00 (+0.22%)
As of 21 Oct 2026

Avg 1-year target

5 of 8 long-term calls BUY

₹5,950.618.7% above today's price

Alkem Laboratories' average 1-year share price target is ₹5,950.6, the average of 5 advisors' latest targets. Targets range from ₹4,590 to ₹6,533.

Latest: Macquarie ₹6,000 · 7 Oct 2026

8
5 BUY · 3 SELL, all horizons
5
with an active 1Y target
25%
3 of 12 closed calls hit
20
all horizons, open and closed
Watch ALKEM for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Alkem Laboratories target price by brokerage

Each advisor's latest 1-year target · 5 advisors · tap a row for the call

All tips (20)

BUYTarget₹6,000
MbyMacquarie+19.6% to target
1 Year* · 12 mo left · 7 Oct 2026 · entry ₹5,297 · via Zee Business (Live)P&L -5.3%
BUYTarget₹6,533
ECbyElara Capital+30.3% to target
1 Year* · 10 mo left · 28 Aug 2026 · entry ₹5,352.5 · via ET Now (Live)P&L -6.3%
SELLTarget₹4,900
MbyMacquarie+2.3% to target
1 Year* · 10 mo left · 17 Aug 2026 · entry ₹5,379.5 · via CNBC Awaaz.P&L +6.8%
BUYTarget₹6,130
NWbyNuvama Wealth+22.2% to target
1 Year* · 10 mo left · 17 Aug 2026 · entry ₹5,379.5 · via ET Now (Live)P&L -6.8%
SELLTarget₹4,590
BCbyBOB Capital Markets+8.5% to target
1 Year* · 10 mo left · 14 Aug 2026 · entry ₹5,368 · via Institutional / Brokerage ResearchP&L +6.6%
SELLTarget₹4,638
BCbyBOB Capital Markets+7.5% to target
1 Year* · 7 mo left · 29 May 2026 · entry ₹5,498 · via Institutional / Brokerage ResearchP&L +8.8%
BUYTarget₹6,500
ISbyICICI Securities+29.6% to target
1 Year* · 4 mo left · 15 Feb 2026 · entry ₹5,402.5 · via Institutional / Brokerage ResearchP&L -7.2%
BUYTarget₹6,600
ISbyICICI Securities+31.6% to target
1 Year* · 3 wk left · 14 Nov 2025 · entry ₹5,722.5 · via Institutional / Brokerage ResearchP&L -12.4%
SELLTarget₹4,527
BCbyBOB Capital MarketsTarget hit
1 Year* · 8 Feb 2025 · entry ₹5,095.05 · via Institutional / Brokerage Researchexit ₹4,527
SELLTarget₹4,800
BCbyBOB Capital MarketsTarget hit
1 Year* · 10 Feb 2024 · entry ₹5,320 · via Institutional / Brokerage Researchexit ₹4,800
BUYTarget₹6,250
SMbySomil Mehta, SharekhanStop-loss hit
1 Year · 14 May 2026 · entry ₹5,618.5 · via Zee Business (Live)exit ₹5,350
BUYTarget₹6,400
ISbyICICI SecuritiesExpired
1 Year* · 19 Sept 2025 · entry ₹5,541.5 · via Institutional / Brokerage Researchexit ₹5,466.5
BUYTarget₹6,065
ISbyICICI SecuritiesExpired
1 Year* · 13 Aug 2025 · entry ₹5,388.5 · via Institutional / Brokerage Researchexit ₹5,449.5
BUYTarget₹7,225
BCbyBOB Capital MarketsExpired
1 Year* · 14 Nov 2024 · entry ₹5,524.95 · via Institutional / Brokerage Researchexit ₹5,722.5
BUYTarget₹5,400
PGbyPrakash GabaTarget hit
1–2 Weeks* · 17 Sept 2026 · entry ₹5,378.5 · via CNBC Awaaz.exit ₹5,400
BUYTarget₹6,150
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 30 Jul 2026 · entry ₹5,689 · via CNBC Awaaz.exit ₹5,680
BUYTarget₹5,850
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 20 Jul 2026 · entry ₹5,646 · via CNBC Awaaz.exit ₹5,550
BUYTarget₹5,774
ISbyICICI SecuritiesExpired
1–2 Weeks* · 6 Jul 2026 · entry ₹5,591 · via Economic Times New Stock Recosexit ₹5,547
BUYTarget₹5,350
SRbySiddharth Rai MangalaExpired
Intraday* · 6 Oct 2026 · entry ₹5,262.5 · via Zee Business (Live)exit ₹5,258
BUYTarget₹5,800
SRbySiddharth Rai MangalaExpired
Intraday* · 29 Jul 2026 · entry ₹5,687.5 · via Zee Business (Live)exit ₹5,671.5

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks